Targeted interleukin-12 inhibition in peristomal pyoderma gangrenosum

Dermatol Ther. 2022 Sep;35(9):e15725. doi: 10.1111/dth.15725. Epub 2022 Aug 2.

Authors

Morgan Vague¹, Wenelia Baghoomian¹, Yuangang Liu¹, Alex G Ortega-Loayza¹

Affiliation

¹ Department of Dermatology, Oregon Health & Science University, Portland, Oregon, USA.

PMID: 35864558
DOI: 10.1111/dth.15725

No abstract available

Publication types

Letter

MeSH terms

Humans
Interleukin-12
Pyoderma Gangrenosum* / drug therapy
Pyoderma Gangrenosum* / etiology
Wound Healing

Substances

Interleukin-12